Works by Cross, Anne H.


Results: 85
    1
    2
    3

    "Brain age" predicts disability accumulation in multiple sclerosis.

    Published in:
    Annals of Clinical & Translational Neurology, 2023, v. 10, n. 6, p. 990, doi. 10.1002/acn3.51782
    By:
    • Brier, Matthew R.;
    • Li, Zhuocheng;
    • Ly, Maria;
    • Karim, Helmet T.;
    • Liang, Leda;
    • Du, Weixin;
    • McCarthy, John E.;
    • Cross, Anne H.;
    • Benzinger, Tammie L. S.;
    • Naismith, Robert T.;
    • Chahin, Salim
    Publication type:
    Article
    4
    5
    6
    7
    8
    9

    Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple Sclerosis.

    Published in:
    JAMA Neurology, 2024, v. 81, n. 4, p. 373, doi. 10.1001/jamaneurol.2024.0017
    By:
    • Cross, Anne H.;
    • Gelfand, Jeffrey M.;
    • Thebault, Simon;
    • Bennett, Jeffrey L.;
    • von Büdingen, H. Christian;
    • Cameron, Briana;
    • Carruthers, Robert;
    • Edwards, Keith;
    • Fallis, Robert;
    • Gerstein, Rachel;
    • Giacomini, Paul S.;
    • Greenberg, Benjamin;
    • Hafler, David A.;
    • Ionete, Carolina;
    • Kaunzner, Ulrike W.;
    • Kodama, Lay;
    • Lock, Christopher;
    • Longbrake, Erin E.;
    • Musch, Bruno;
    • Pardo, Gabriel
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive patients with multiple sclerosis: Results from ASCLEPIOS I and II.

    Published in:
    Multiple Sclerosis Journal, 2022, v. 28, n. 10, p. 1562, doi. 10.1177/13524585221078825
    By:
    • Gärtner, Jutta;
    • Hauser, Stephen L;
    • Bar-Or, Amit;
    • Montalban, Xavier;
    • Cohen, Jeffrey A;
    • Cross, Anne H;
    • Deiva, Kumaran;
    • Ganjgahi, Habib;
    • Häring, Dieter A;
    • Li, Bingbing;
    • Pingili, Ratnakar;
    • Ramanathan, Krishnan;
    • Su, Wendy;
    • Willi, Roman;
    • Kieseier, Bernd;
    • Kappos, Ludwig
    Publication type:
    Article
    21

    Safety experience with continued exposure to ofatumumab in patients with relapsing forms of multiple sclerosis for up to 3.5 years.

    Published in:
    Multiple Sclerosis Journal, 2022, v. 28, n. 10, p. 1576, doi. 10.1177/13524585221079731
    By:
    • Hauser, Stephen L;
    • Cross, Anne H;
    • Winthrop, Kevin;
    • Wiendl, Heinz;
    • Nicholas, Jacqueline;
    • Meuth, Sven G;
    • Giacomini, Paul S;
    • Saccà, Francesco;
    • Mancione, Linda;
    • Zielman, Ronald;
    • Bagger, Morten;
    • Das Gupta, Ayan;
    • Häring, Dieter A;
    • Jehl, Valentine;
    • Kieseier, Bernd C;
    • Pingili, Ratnakar;
    • Stoneman, Dee;
    • Su, Wendy;
    • Willi, Roman;
    • Kappos, Ludwig
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33

    Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis.

    Published in:
    Multiple Sclerosis Journal, 2013, v. 19, n. 14, p. 1938, doi. 10.1177/1352458513485654
    By:
    • Fenoglio, Chiara;
    • Ridolfi, Elisa;
    • Cantoni, Claudia;
    • De Riz, Milena;
    • Bonsi, Rossana;
    • Serpente, Maria;
    • Villa, Chiara;
    • Pietroboni, Anna M;
    • Naismith, Robert T;
    • Alvarez, Enrique;
    • Parks, Becky J;
    • Bresolin, Nereo;
    • Cross, Anne H;
    • Piccio, Laura M;
    • Galimberti, Daniela;
    • Scarpini, Elio
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41

    Increased White Matter Aerobic Glycolysis in Multiple Sclerosis.

    Published in:
    Annals of Neurology, 2025, v. 97, n. 4, p. 766, doi. 10.1002/ana.27165
    By:
    • Brier, Matthew R;
    • Judge, Bradley;
    • Ying, Chunwei;
    • Salter, Amber;
    • An, Hongyu;
    • Patel, Aakash;
    • Wang, Qing;
    • Wang, Yong;
    • Cross, Anne H;
    • Naismith, Robert T;
    • Benzinger, Tammie LS;
    • Goyal, Manu S
    Publication type:
    Article
    42

    Unexpected Low Rate of Amyloid‐β Pathology in Multiple Sclerosis Patients.

    Published in:
    Annals of Neurology, 2024, v. 96, n. 3, p. 453, doi. 10.1002/ana.27027
    By:
    • Brier, Matthew R.;
    • Schindler, Suzanne E.;
    • Salter, Amber;
    • Perantie, Dana;
    • Shelley, Nicole;
    • Judge, Bradley;
    • Keefe, Sarah;
    • Kirmess, Kristopher M.;
    • Verghese, Philip B.;
    • Yarasheski, Kevin E.;
    • Venkatesh, Venky;
    • Raji, Cyrus A.;
    • Gordon, Brian A.;
    • Bateman, Randall J.;
    • Morris, John C.;
    • Naismith, Robert T.;
    • Holtzman, David M.;
    • Benzinger, Tammie L.S.;
    • Cross, Anne H.
    Publication type:
    Article
    43
    44
    45
    46

    Ofatumumab Versus Teriflunomide in Relapsing Multiple Sclerosis: Analysis of No Evidence of Disease Activity (NEDA-3) from the ASCLEPIOS I and II Trials.

    Published in:
    International Journal of MS Care, 2020, v. 22, n. S2, p. 85
    By:
    • Hauser, Stephen L.;
    • Bar-Or, Amit;
    • Cohen, Jeffrey A.;
    • Comi, Giancarlo;
    • Correale, Jorge;
    • Coyle, Patricia K.;
    • Cross, Anne H.;
    • de Seze, Jérôme;
    • Montalban, Xavier;
    • Selmaj, Krzysztof;
    • Wiendl, Heinz;
    • Willi, Roman;
    • Bingbing Li;
    • Häring, Dieter A.;
    • Ramanathan, Krishnan;
    • Merschhemke, Martin;
    • Kappos, Ludwig
    Publication type:
    Article
    47

    Effect of Ofatumumab on Serum Immunoglobulin Levels and Infection Risk in Relapsing Multiple Sclerosis Patients from the Phase 3 ASCLEPIOS I and II Trials.

    Published in:
    International Journal of MS Care, 2020, v. 22, n. S2, p. 85
    By:
    • de Seze, Jérôme;
    • Or, Amit Bar;
    • Correale, Jorge;
    • Cross, Anne H.;
    • Kappos, Ludwig;
    • Selmaj, Krzysztof;
    • Wiendl, Heinz;
    • Kerloeguen, Cecile;
    • Goodyear, Alexandra;
    • Pingili, Ratnakar;
    • Sullivan, Roseanne;
    • Gupta, Ayan Das;
    • Jehl, Valentine;
    • Häring, Dieter A.;
    • Merschhemke, Martin;
    • Hauser, Stephen L.
    Publication type:
    Article
    48
    49

    (DMT03) Efficacy and Safety of Ofatumumab Versus Teriflunomide in Patients with Relapsing Multiple Sclerosis: Phase 3 ASCLEPIOS I and II Trials.

    Published in:
    International Journal of MS Care, 2020, v. 22, n. S2, p. 4
    By:
    • Cross, Anne H.;
    • Kappos, Ludwig;
    • Bar-Or, Amit;
    • Cohen, Jeffrey A.;
    • Comi, Giancarlo;
    • Correale, Jorge;
    • Coyle, Patricia K.;
    • de Seze, Jerome;
    • Leppert, David;
    • Montalban, Xavier;
    • Selmaj, Krzysztof W.;
    • Wiendl, Heinz;
    • Kerloeguen, Cecile;
    • Willi, Roman;
    • Bingbing Li;
    • Kakarieka, Algirdas;
    • Tomic, Davorka;
    • Goodyear, Alexandra;
    • Pingili, Ratnakar;
    • Haering, Dieter A.
    Publication type:
    Article
    50